Novavax(DE:NVV1)
€9.03-0.17 (-1.85%)
DE:NVV1
Novavax ownership
€9.03
At close:-0.17 (-1.85%)
Novavax (NVV1) Ownership - Who Owns Novavax?
9 Followers
Novavax (NVV1) Ownership Overview
- 0.58% Insiders
- 13.50% Mutual Funds
- 14.15% Other Institutional Investors
- 20.42% ETFs
- 51.35% Public Companies and Individual Investors
The ownership structure of Novavax (DE:NVV1) stock is a mix of institutional, retail, and individual investors. Approximately 48.07% of the company’s stock is owned by Institutional Investors, 0.58% is owned by Insiders, and 51.35% is owned by Public Companies and Individual Investors.
The ownership structure of Novavax (DE:NVV1) stock is a mix of institutional, retail, and individual investors. Approximately 48.07% of the company’s stock is owned by Institutional Investors, 0.58% is owned by Insiders, and 51.35% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Graham Capital Management, L.p. | €272,966 | |
| Dec 31, 2025 | Farallon Capital Management, L.l.c. | €1,310,400 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 14,314,859 | Institution | 8.68% | 143,434,887 |
| BlackRock, Inc. | 13,946,881 | Institution | 8.45% | 139,747,748 |
| Vanguard Index Funds | 13,020,004 | Institution | 7.89% | 130,460,440 |
| Ishares | 8,531,857 | Institution | 5.17% | 85,489,207 |
| Spdr | 5,624,818 | Institution | 3.41% | 56,360,676 |
| Philippe Laffont | 3,836,986 | Institution | 2.33% | 38,446,600 |
| Fidelity Salem Street Trust | 1,906,355 | Institution | 1.16% | 19,101,677 |
| Fidelity Concord Street Trust | 1,591,157 | Institution | 0.96% | 15,943,393 |
| Invesco | 1,426,559 | Institution | 0.86% | 14,294,121 |
| Vanguard Scottsdale Funds | 1,029,254 | Institution | 0.62% | 10,313,125 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 13,020,004 | Institution | 7.89% | 130,460,440 |
| Fidelity Salem Street Trust | 1,906,355 | Institution | 1.16% | 19,101,677 |
| Fidelity Concord Street Trust | 1,591,157 | Institution | 0.96% | 15,943,393 |
| Vanguard Scottsdale Funds | 1,029,254 | Institution | 0.62% | 10,313,125 |
| Pimco Equity Series | 1,015,460 | Institution | 0.62% | 10,174,909 |
| Federated Hermes Mdt Series | 692,795 | Institution | 0.42% | 6,941,806 |
| Tiaa-cref Funds | 538,595 | Institution | 0.33% | 5,396,722 |
| Schwab Capital Trust | 467,174 | Institution | 0.28% | 4,681,083 |
| Vanguard World Fund | 421,614 | Institution | 0.26% | 4,224,572 |
| Goldman Sachs Trust | 281,882 | Institution | 0.17% | 2,824,458 |
FAQ
Who Owns Novavax (DE:NVV1)?
According to the latest TipRanks data, approximately 48.07% of the company's stock is held by institutional investors, 0.58% is held by insiders, and 51.35% is held by public companies and individual investors.
What percentage of Novavax (DE:NVV1) stock is held by institutional investors?
According to the latest TipRanks data, approximately 48.07% of Novavax (DE:NVV1) stock is held by institutional investors: 13.50% by mutual funds, 20.42% by ETFs and 14.15% by other institutional investors.
What percentage of Novavax (DE:NVV1) stock is held by retail investors?
According to the latest TipRanks data, approximately 51.35% of Novavax (DE:NVV1) stock is held by public companies and individual investors.
Who owns the most shares of Novavax (DE:NVV1)?
Vanguard owns the most shares of Novavax (DE:NVV1).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
